ANI Pharmaceuticals, Inc. (ANIP) — Stock Price, Chart & Analysis
ANI Pharmaceuticals, Inc. (ANIP) is a Healthcare stock currently trading at $78.25, down 5.30% on the day. It carries a market capitalization of $1.78B and a trailing P/E ratio of 17.05. Over the past 52 weeks, ANIP has traded between $70.15 and $99.50. ANI Pharmaceuticals, Inc. does not currently pay a regular dividend. View the live ANIP chart, technical opinion, analyst ratings, fundamentals and latest news below.
ANI Pharmaceuticals, Inc. (ANIP) key data
| Price | $78.25 |
| Change (today) | -5.30% |
| Previous close | $82.63 |
| Market cap | $1.78B |
| P/E ratio (TTM) | 17.05 |
| EPS (TTM) | $4.59 |
| 52-week high | $99.50 |
| 52-week low | $70.15 |
| Beta | 0.46 |
| Avg. volume | 341.3K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently asked questions about ANI Pharmaceuticals, Inc. (ANIP)
How much does one share of ANI Pharmaceuticals, Inc. cost?
As of the latest update, one share of ANI Pharmaceuticals, Inc. (ANIP) trades at $78.25 (-5.30% today).
What is ANI Pharmaceuticals, Inc.'s market cap?
ANI Pharmaceuticals, Inc. has a market capitalization of approximately $1.78B.
What is ANI Pharmaceuticals, Inc.'s P/E ratio?
ANI Pharmaceuticals, Inc. has a trailing price-to-earnings (P/E) ratio of 17.05.
What is ANI Pharmaceuticals, Inc.'s earnings per share (EPS)?
ANI Pharmaceuticals, Inc.'s trailing twelve-month EPS is $4.59.
Does ANI Pharmaceuticals, Inc. pay a dividend?
ANI Pharmaceuticals, Inc. does not currently pay a regular dividend.
What is ANI Pharmaceuticals, Inc.'s 52-week trading range?
Over the past year, ANIP has traded between $70.15 and $99.50.
What is the analyst price target for ANI Pharmaceuticals, Inc.?
The mean analyst price target for ANI Pharmaceuticals, Inc. is $110.00. This is informational only and not investment advice.
Latest ANI Pharmaceuticals, Inc. (ANIP) news
- ANI Pharmaceuticals, Inc. Q2 2026 Earnings Call SummaryNews · Aug 7, 2026
- ANI Pharmaceuticals Inc (ANIP) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic ...News · Aug 7, 2026
- ANI Pharmaceuticals Q2 Earnings Call HighlightsNews · Aug 7, 2026
- ANI Pharmaceuticals Shares Slide Despite Earnings Beat After Cortrophin Outlook CutNews · Aug 7, 2026
- Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key MetricsNews · Aug 7, 2026
- ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Beat EstimatesNews · Aug 7, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live ANIP dashboard…